热门资讯> 正文
Quantum BioPharma对GameStop进行战略投资
2025-07-22 19:15
- Quantum BioPharma (NASDAQ:QNTM), a biopharmaceutical company focused on treatments for neurodegenerative disorders, has acquired 2,000 shares of GameStop (NYSE:GME) as a strategic investment to be held on its balance sheet.
- “The Quantum team and I see the extreme value in GameStop going forward and the deep value the company has with 90% cash and marketable securities on their balance sheet,” said Kevin Malone, Board Advisor to Quantum BioPharma.
- QNTM +4.18% premarket.
- Source: Press Release
More on GameStop, Quantum BioPharma
- GameStop: No More Memes, But The Trading Card Age Is Just Beginning (Surprising Rating Upgrade)
- GameStop: An Option On What? (Upgrade)
- GameStop Needs An Aggressive And Coherent Crypto Business Model If It Wants To Silence The Bears
- Insider trades: Broadcom insiders trim holdings for fourth straight week
- GameStop prices upsized private offering of $2.25B senior notes
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
